Skip Ribbon Commands
Skip to main content
Home Administrative Billing & Reimbursement BlueCard® Health and Wellness Medical PEAR portal Pharmacy Products Quality Management

Orthovisc® replaces Euflexxa® as one of three preferred products to treat osteoarthritis of the knee

April 18, 2013

Effective April 1, 2013, IBC has designated Orthovisc?, Synvisc?, and Synvisc-One? as our preferred hyaluronate acid products for the treatment of osteoarthritis of the knee. We encourage providers to choose one of the three preferred products when treating members who have osteoarthritis of the knee. For additional information on the three preferred products to treat osteoarthritis of the knee, read the news article, []Orthovisc? replaces Euflexxa? as one of three preferred products to treat osteoarthritis of the knee[], located on our Medical Policy portal.

This content was prepared for the Provider News Center and may not be reproduced in any way without the express written permission of Independence Blue Cross. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.
Connect with us     Facebook     Twitter     Flickr     YouTube     Walk the Talk    Independence Pinterest    Independence LinkedIn    Independence Instagram Site Map        Anti-Fraud        Privacy Policy        Legal        Disclaimer
© 2025 Independence Blue Cross.
Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association, serving the health insurance needs of Philadelphia and southeastern Pennsylvania.